Skip to content

Clinical trials

Muscular Dystrophy, Facioscapulohumeral trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Facioscapulohumeral Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20081
20102
20111
20122
20133
20145
20154
20166
20172
20181
20195
20202
20212
20223
20236
202413
20258
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting17
Active, not recruiting5
Terminated5
Enrolling by invitation4
Unknown status3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire de Nice5
aTyr Pharma, Inc.5
Avidity Biosciences, Inc.3
Fulcrum Therapeutics3
LMU Klinikum3
University of Kansas Medical Center3
University of Rochester3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Centre Hospitalier Universitaire de Liege2
Centre Hospitalier Universitaire de Saint Etienne2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Facioscapulohumeral75
Muscular Dystrophies17
Neuromuscular Diseases12
Myotonic Dystrophy10
Muscular Dystrophy, Duchenne8
Muscular Dystrophies, Limb-Girdle6
Charcot-Marie-Tooth Disease5
Muscular Atrophy, Spinal5
Myositis, Inclusion Body5
Lambert-Eaton Myasthenic Syndrome4

Trials

Showing 51 to 75 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.